United States · FDA National Drug Code directory

Levothyroxine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-222_aca8c79e-06fa-4919-bc65-a2aff5429fde
Product NDC
71205-222
Form
TABLET
Composition / generic term
Levothyroxine Sodium
Labeler
Proficient Rx LP
Marketing category
NDA
Marketing start / end (source format)
20031201
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — .112 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE, PLASTIC (71205-222-30) · 71205-222-30
  • 60 TABLET in 1 BOTTLE, PLASTIC (71205-222-60) · 71205-222-60
  • 90 TABLET in 1 BOTTLE, PLASTIC (71205-222-90) · 71205-222-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →